Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/19
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 11/30/20
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 10/13/20
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform | NCT04100811 | miR Scientific LLC | user2@example.com | None | 2019-12-01 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |
| Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico | NCT04661176 | miR Scientific LLC | user2@example.com | None | 2020-11-30 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |
| Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients | NCT04155359 | miR Scientific LLC | user2@example.com | None | 2020-10-13 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |